[Research Report] The infertility testing market is projected to grow from US$ 424.20 million in 2022 to US$ 820.08 million by 2030; the market is estimated to record a CAGR of 8.6% during 2022–2030.
Market Insights and Analyst View:
Factors such as the increasing cases of infertility in men and women and growing advancements in infertility testing propel the market growth. However, lack of awareness and limitations associated with infertility testing kits impede the market growth.
In the area of reproductive ability, infertility refers to a deficiency that neither affects the individual's physical performance nor is life-threatening. However, it could affect the development of individual (both men and women), weakening their personality and causing frustration. Approximately 50 to 80 million couples experience infertility problems at least once in their reproductive lives. The situation of infertility is different in developing countries than in developed countries. According to the World Health Organization (WHO), one in six couples suffers from infertility problems. Increasing awareness about testing and changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are contributing to the growing infertility testing market size. Furthermore, technological advancements in ovulation monitors propel the market growth. Rising consumption of smoking and tobacco will lead to an increase in infertility cases, bolstering the demand for infertility testing. In addition, increasing awareness about fertility, the growing female population affected by PCOS, rising demand for self-testing and remote monitoring testing among men and women, and innovation of new products are expected to create opportunities for the infertility testing market during the forecast period.
Growth Drivers:
Increasing Cases of Infertility in Men and Women Drive Infertility Testing Market Growth
Infertility in males is a globally prevalent issue, with percentages varying from one region to another. According to the WHO, for ~20% of infertile couples, the problem is with male partners, whereas in 30% of couples, the infertility issue is with both partners. Common factors responsible for causing infertility in men are low levels of hormones made in the pituitary gland, deficiency in semen and semen quality, sexual issues affecting the entry of semen into the vaginal track, and presence of sperm antibodies. The most common cause responsible for low sperm count is varicocele, an enlarged vein in the testicle. According to the US Department of Health and Human Services, varicocele is present in about 40% of men suffering from infertility problems. The low sperm count leads to infertility in men, which boosts the infertility testing market.
The fertility rate is steadily declining across the world, owing to several factors such as late marriages and increasing age-related infertility. According to the WHO, there were an estimated 128.5 million new chlamydia infections in adults (15–49 years) worldwide in 2020. The prevalence of chlamydia infections in people aged 15–49 years was estimated at 4.0% for women and 2.5% for men. According to the Centers for Disease Control and Prevention (CDC), in the US, about 10% of women (6.1 million) aged 15 to 44 have trouble in getting or staying pregnant. Thus, the declining fertility rate propels the demand for infertility testing to determine the reasons for infertility in males and females, thereby driving the infertility testing market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infertility Testing Market: Strategic Insights
Market Size Value in US$ 424.20 million in 2022 Market Size Value by US$ 820.08 million by 2030 Growth rate CAGR of 8.6% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infertility Testing Market: Strategic Insights
| Market Size Value in | US$ 424.20 million in 2022 |
| Market Size Value by | US$ 820.08 million by 2030 |
| Growth rate | CAGR of 8.6% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “infertility testing market analysis” has been carried out by considering the following segments: type, test kits, sample, and end user.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
The infertility testing market, by type, is bifurcated into male infertility testing and female infertility testing. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period. Increasing stress levels, obesity, smoking, and alcohol consumption are among the factors that contribute to male infertility. Furthermore, growing awareness regarding infertility, increasing research and development expenditure, initiatives by major infertility testing market players to launch their products, and changing lifestyles fuel the market growth for the male infertility testing segment.
By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. The human follicular stimulating hormone (FSH) test kits segment held the largest market share in 2022 and is anticipated to record the highest CAGR of 9.2% during the forecast period. The follicular stimulating hormone (FSH) test kit helps in measuring the concentration of FSH hormone present in the blood. The test is often used to assess FSH levels in men and women for various reasons such as fertility problems, menopause, or problems with sexual development. FSH helps control menstrual cycle of a woman and the growth of follicles that contain eggs in the ovaries. In men, FSH regulates the production and transport of sperm. The test is used to determine the sperm count. Therefore, an FSH test kit is an important diagnostic tool for assessing reproductive problems and other conditions related to hormonal imbalances. In addition, advanced biosimilar FSH products, regulatory approvals, market access, technological advances in FSH kit production, and a growing need for effective contraceptive options are predicted to accelerate the global market growth.
By sample, the infertility testing market is segmented into blood, urine, and others. The blood segment held the largest market share in 2022. The same segment is anticipated to register the highest CAGR of 9.1% during the forecast period. Infertility tests are usually blood tests to measure important hormones. Depending on the couple's situation, woman or man may require different blood tests. Blood tests that may be needed include follicular stimulating hormone (FSH), anti-Müllerian hormone (AMH), luteinizing hormone (LH), and others. In January 2021, health start-up Yesmom launched Asia's first at-home female fertility blood test kits to help women prioritize their reproductive health from the comfort of their homes.
Infertility Testing Market Share, by Sample – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
By end user, the infertility testing market is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period. The segment is expected to grow owing to patient preference for self-monitoring of health conditions, easy access to fertility testing kits on e-commerce websites, availability of user-friendly and easy-to-use devices, and growing preference for the confidentiality of test results.
Adoption of Assisted Reproductive Technologies (ART) and In Vitro Fertilization (IVF) to Accelerate Infertility Testing Market
Growing awareness about infertility is expected to spur the demand for the treatments of IVF and ART in the coming years. Introduction of advanced treatment of intra cytoplasmic sperm injection and rising awareness about the medicinal and surgical procedures for IVF treatment are expected to drive the infertility testing market during the forecast period. According to UCSF Health, ~ 10% of infertility issues are due to unknown causes, and the other 30% are due to problems in male and female partners.
Common procedures performed in men include intracytoplasmic sperm injection (ICSI), epididymal aspirations, vassal aspiration, testicular sperm extraction, and mapping of the failing tests. Around 75% of men with a male factor have identifiable or treatable conditions affecting their fertility. Moreover, almost all men having male factor infertility are usually treatable with ARTs. Thus, the growing adoption of ART and IVF is likely to bring new infertility testing market trends in the coming years.
Regional Analysis:
The scope of the infertility testing market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
In 2022, North America held the largest infertility testing market share. The market growth in this region is driven by the high occurrence of infertility, increasing awareness of infertility testing among men and women, rising age of first pregnancy among women, and easy availability of infertility test kits through e-commerce websites. Furthermore, the increasing prevalence of smoking and tobacco consumption will lead to an increase in infertility cases, propelling the market growth. Increasing testing awareness and the growing female population affected by PCOS are also accelerating the market growth.
The infertility testing market in Europe is expected to hold the third-largest share of the global market. The European market growth is driven by increasing awareness regarding infertility issues, diabetic population, and presence of a large number of players in the region along with government initiatives related to fertility. According to the European Society of Human, Reproductive and Embryology, infertility was estimated to affect over 25 million people across Europe in 2021. In Europe, one child per primary school class is born using assisted reproductive technologies (ART), and in the Nordic countries, between 2 and 7% of births come from ART. Spain is one of the preferred destination countries for infertility treatment as it has a progressive legal framework compared to other EU countries, high level of infertility professionals, excellent facilities, and advanced medical technologies. Fertility Europe (FE) is the umbrella organization of European associations involved with infertility issues in over 20 European countries. They aim to improve the rights of those affected by infertility, build a strong cross-border network amongst European patients to achieve and share best practices, promote social awareness about infertility and promote education in the area of the protection of reproductive health.
The infertility testing market in Asia Pacific is expected to witness the fastest growth rate of 9.1% during the forecast period. The regional market growth is attributed to an increase in the number of women affected by lifestyle disorders, rise in funding/investments in the development of infertility testing products, and upsurge in focus by international and domestic players on the Asia Pacific infertility test market.
Industry Developments and Future Opportunities:
The infertility testing market forecast can help stakeholders in this marketplace plan their growth strategies. As per the press releases by leading players operating in the market, a few strategic developments are listed below:
- In July 2023, 2San, a respected global leader in self-diagnostic testing, partnered with Proov to launch its exclusive, easy-to-use at-home fertility tests at hand-selected Hy-Vee stores in eight Midwestern states.
- In January 2022, Kindbody, a leading fertility and family-building care provider, introduced Kind at Home, its consumer products division dedicated to support people throughout their reproductive journey. The initiative began with the introduction of user-friendly home fertility hormone tests for women and men.
- In December 2021, Carrot Fertility announced the launch of a new kit to help people monitor fertility hormones and related biomarkers at home. A customized, testing kit provides a more comprehensive picture of fertility health, enabling earlier action and interventions from the comfort of home.
Competitive Landscape and Key Companies:
Merck KgaA; Procter & Gamble; bioMerieux SA; Alere Inc.; Babystart Ltd.; bioZhena Corporation; Quidel Corporation; CENTOGENE N.V.; SCSA Diagnostics, Inc.; and Boditech Med Inc. are among the prominent companies profiled in the infertility testing market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to fulfil the growing consumer demand across the world.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Test Kits, Sample, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Infertility is defined as the failure to attain a clinical pregnancy after a minimum duration of one year of regular and timely attempts, which was later known to include physiological or psychological conditions that were inconsistent with the natural encounter of the gametes. Rising awareness about testing, technological advancements in ovulation monitors, and changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are among the significant factors responsible for the infertility testing market growth.
The factors driving the growth of the infertility testing market include the increasing cases of infertility in men and women and growing advancements in infertility testing.
The infertility testing market majorly consists of the players such as Merck KgaA; Procter & Gamble; bioMerieux SA; Alere Inc.; Babystart Ltd.; bioZhena Corporation; Quidel Corporation; CENTOGENE N.V.; SCSA Diagnostics, Inc.; and Boditech Med Inc.
The infertility testing market was valued at US$ 424.20 million in 2022.
The infertility testing market is expected to be valued at US$ 820.08 million in 2030.
The global infertility testing market, based on type, the infertility testing market analysis is carried out by considering the following segments: male infertility testing and female infertility testing. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period. By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. In terms of revenue, the human follicular stimulating hormone (FSH) test kits segment dominated the infertility testing market share in 2022. The same is anticipated to register the highest CAGR of 9.2% during the forecast period. The infertility testing market, based on sample, is segmented into blood, urine, and others. The blood segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.1% during the forecast period. The infertility testing market, by end user, is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Infertility Testing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Infertility Testing Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Infertility Testing Market - Global Market Analysis
6.1 Infertility Testing - Global Market Overview
6.2 Infertility Testing - Global Market and Forecast to 2031
7. Infertility Testing Market – Revenue Analysis (USD Million) – By Type, 2021-2031
7.1 Overview
7.2 Female Infertility Testing
7.3 Male Infertility Testing
8. Infertility Testing Market – Revenue Analysis (USD Million) – By Test Kits, 2021-2031
8.1 Overview
8.2 Human Follicular Stimulating Hormone (FSH) Urine Test Kits
8.3 Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
8.4 Luteinizing Hormone (LH) Test Kits
8.5 Others
9. Infertility Testing Market – Revenue Analysis (USD Million) – By Sample, 2021-2031
9.1 Overview
9.2 Blood
9.3 Urine
9.4 Others
10. Infertility Testing Market – Revenue Analysis (USD Million) – By End User, 2021-2031
10.1 Overview
10.2 Hospitals & Clinics
10.3 Fertility Centers
10.4 Homecare
11. Infertility Testing Market - Revenue Analysis (USD Million), 2021-2031 – Geographical Analysis
11.1 North America
11.1.1 North America Infertility Testing Market Overview
11.1.2 North America Infertility Testing Market Revenue and Forecasts to 2031
11.1.3 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Type
11.1.4 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Test Kits
11.1.5 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Sample
11.1.6 North America Infertility Testing Market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Infertility Testing Market
11.1.7.1.1 United States Infertility Testing Market, by Type
11.1.7.1.2 United States Infertility Testing Market, by Test Kits
11.1.7.1.3 United States Infertility Testing Market, by Sample
11.1.7.1.4 United States Infertility Testing Market, by End User
11.1.7.2 Canada Infertility Testing Market
11.1.7.2.1 Canada Infertility Testing Market, by Type
11.1.7.2.2 Canada Infertility Testing Market, by Test Kits
11.1.7.2.3 Canada Infertility Testing Market, by Sample
11.1.7.2.4 Canada Infertility Testing Market, by End User
11.1.7.3 Mexico Infertility Testing Market
11.1.7.3.1 Mexico Infertility Testing Market, by Type
11.1.7.3.2 Mexico Infertility Testing Market, by Test Kits
11.1.7.3.3 Mexico Infertility Testing Market, by Sample
11.1.7.3.4 Mexico Infertility Testing Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East & Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East & Africa
11.5 South & Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South & Central America
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Infertility Testing Market - Key Company Profiles
14.1 Merck KGaA
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 Procter & Gamble
14.3 bioMérieux SA
14.4 Alere Inc.
14.5 Babystart Ltd.
14.6 bioZhena Corporation
14.7 Quidel Corporation
14.8 SCSA Diagnostics, Inc.
14.9 CENTOGENE N.V.
14.10 Boditech Med Inc.
15. Appendix
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
The List of Companies - Infertility Testing Market
- Merck KgaA
- Procter & Gamble
- bioMerieux SA
- Alere Inc.
- Babystart Ltd.
- bioZhena Corporation
- Quidel Corporation
- CENTOGENE N.V
- SCSA Diagnostics, Inc.
- Boditech Med Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Infertility Testing Market
Mar 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)